(Q40619901)

22 September 2017

Pharmacokinetics of cefamandole in patients with renal impairment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A426510

https://api.crossref.org/works/10.1128/AAC.15.2.161

30 June 2022

Pharmacokinetics of Cefamandole in Patients with Renal Impairment (English)

1 reference

1 May 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.15.2.161

1 May 2023

author name string

A. W. Czerwinski

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A426510

30 June 2022

J. A. Pederson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A426510

30 June 2022

language of work or name

English

0 references

publication date

1 February 1979

1 reference

PMCID

352626

full work available at URL

22 September 2017

https://europepmc.org/articles/PMC352626

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A426510

https://europepmc.org/articles/PMC352626?pdf=render

30 June 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A426510

https://journals.asm.org/doi/pdf/10.1128/AAC.15.2.161

30 June 2022

1 reference

https://api.crossref.org/works/10.1128/AAC.15.2.161

Antimicrobial Agents and Chemotherapy

1 May 2023

published in

1 reference

22 September 2017

15

1 reference

22 September 2017

161-164

1 reference

22 September 2017

2

1 reference

Pharmacological Studies with Cefamandole in Human Volunteers

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352626

Cefamandole: in vitro and clinical pharmacokinetics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352626

Pharmacokinetics of cefamandole in patients with normal and impaired renal function

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352626

Pharmacokinetics of cefamandole in patients with renal failure

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352626

Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352626

Drug dosage in patients with impaired renal function

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352626

Antimicrobial dosage in renal failure: a unifying nomogram

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/426510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.15.2.161

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

PMCID

352626